Table: Aska Pharmaceutical -2019/20 group results

ASKA Pharmaceutical Holdings

12/05/2020 07:00

May 12 (Reuters)- 
          Aska Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           52.54           46.71          53.00                 
               (+12.5 pct)     (-4.6 pct)     (+0.9 pct)               
  Operating        1.51            1.78           2.00                 
               (-15.5 pct)     (-36.9 pct)    (+32.7 pct)              
  Recurring        1.72            1.98           1.90                 
               (-13.4 pct)     (-35.6 pct)    (+10.8 pct)              
  Net
  Net            649 mln           1.74           1.50                 
               (-62.8 pct)     (-27.0 pct)   (+131.1 pct)              
  EPS           22.96 yen       61.81 yen      52.95 yen               
  Ann Div       17.00 yen       14.00 yen      14.00 yen               
  -Q2 Div       7.00 yen        7.00 yen       7.00 yen                
  -Q4 Div       10.00 yen       7.00 yen       7.00 yen                
  
  NOTE - Aska Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T